ASCENDIS PHARMA A/S -
124.33
08-November-24 15:59:59
15 minutes delayed
Stocks
-2.22
-1.75%
Today's range
124.11 - 128.20
ISIN
N/A
Source
NASDAQ
-
07 Nov 2024 16:01:00 By Nasdaq GlobeNewswire
-
04 Nov 2024 07:00:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
30 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
19 Sep 2024 20:16:32 By Nasdaq GlobeNewswire
-
Ascendis Pharma A/S Announces Proposed Public Offering of ADSs
18 Sep 2024 16:04:11 By Nasdaq GlobeNewswire
-
16 Sep 2024 07:00:00 By Nasdaq GlobeNewswire
-
13 Sep 2024 08:30:00 By Nasdaq GlobeNewswire
-
11 Sep 2024 17:37:50 By Nasdaq GlobeNewswire
-
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
03 Sep 2024 17:06:29 By Nasdaq GlobeNewswire
-
Ascendis Pharma Reports Second Quarter 2024 Financial Results
03 Sep 2024 17:04:32 By Nasdaq GlobeNewswire
-
28 Aug 2024 08:30:00 By Nasdaq GlobeNewswire
-
12 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
24 Jun 2024 16:45:36 By Nasdaq GlobeNewswire
-
Ascendis Pharma to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
04 Jun 2024 16:01:00 By Nasdaq GlobeNewswire
-
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
03 Jun 2024 16:01:00 By Nasdaq GlobeNewswire
-
Ascendis to Spotlight Latest Updates for TransCon™ Rare Endocrinology Disease Portfolio at ENDO 2024
30 May 2024 08:30:00 By Nasdaq GlobeNewswire
-
14 May 2024 14:31:44 By Nasdaq GlobeNewswire
-
09 May 2024 08:30:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >